- Home
- / Samjin Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Samjin Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩18.2 K
2024-10-29
Market Capitalization
₩227.6 B
2024-10-29
Revenue
₩309.1 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 260.0B | 241.9B | 235.2B | 250.1B | 274.0B | 292.1B | 308.3B | 309.1B |
| Cost of goods sold | 62.4B | 65.5B | 62.7B | 70.0B | 113.0B | 159.9B | 163.0B | 165.5B |
| Gross profit | 197.7B | 176.9B | 172.8B | 180.3B | 162.0B | 133.4B | 170.0B | 144.3B |
| Gross profit margin, % | 76.0% | 73.1% | 73.5% | 72.1% | 59.1% | 45.7% | 55.1% | 46.7% |
| Operating expense total | 131.8B | 125.9B | 133.8B | 138.8B | 125.7B | 95.1B | 96.3B | 97.1B |
| Depreciation and amortization | 6.1B | 6.4B | 6.4B | 7.4B | 9.6B | 16.6B | 17.5B | 19.9B |
| EBITDA | 65.9B | 51.0B | 39.0B | 41.5B | 36.0B | 38.2B | 72.3B | 47.5B |
| EBITDA margin, % | 25.3% | 21.1% | 16.6% | 16.6% | 13.1% | 13.1% | 23.5% | 15.4% |
| EBIT | 59.4B | 20.6B | 32.2B | 33.7B | 26.3B | 20.0B | 49.5B | 26.2B |
| EBIT margin, % | 22.8% | 8.5% | 13.7% | 13.5% | 9.6% | 6.8% | 16.0% | 8.5% |
| Interest income | 615.7M | 406.2M | 343.9M | 215.1M | 153.5M | 89.4M | 192.3M | 369.1M |
| Interest expense | 34.9M | 24.1M | 41.7M | 141.9M | 1.8B | 4.4B | 4.9B | 5.0B |
| Pre tax profit | 60.1B | 21.1B | 32.8B | 34.9B | 25.2B | 15.6B | 43.6B | 22.1B |
| Income tax expense | 34.5B | 9.8B | 5.0B | 6.5B | 3.3B | (5.1B) | 4.4B | (2.1B) |
| Net Income | 25.5B | 11.3B | 27.9B | 28.4B | 21.9B | 20.6B | 39.2B | 24.2B |